Effect of dolutegravir in combination with nucleoside reverse transcriptase inhibitors on people living with HIV who have pre-existing nucleoside reverse transcriptase inhibitor mutations
International Journal of Antimicrobial Agents | Jan 28, 2018
Most read this week